Literature DB >> 22405007

Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody.

Byron Carpenter1, Glyn R Hemsworth, Zida Wu, Mabrouka Maamra, Christian J Strasburger, Richard J Ross, Peter J Artymiuk.   

Abstract

Leptin regulates energy homeostasis, fertility, and the immune system, making it an important drug target. However, due to a complete lack of structural data for the obesity receptor (ObR), leptin's mechanism of receptor activation remains poorly understood. We have crystallized the Fab fragment of a leptin-blocking monoclonal antibody (9F8), both in its uncomplexed state and bound to the leptin-binding domain (LBD) of human ObR. We describe the structure of the LBD-9F8 Fab complex and the conformational changes in 9F8 associated with LBD binding. A molecular model of the putative leptin-LBD complex reveals that 9F8 Fab blocks leptin binding through only a small (10%) overlap in their binding sites, and that leptin binding is likely to involve an induced fit mechanism. This crystal structure of the leptin-binding domain of the obesity receptor will facilitate the design of therapeutics to modulate leptin signaling. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405007     DOI: 10.1016/j.str.2012.01.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  23 in total

1.  Uncovering the molecular mechanisms behind disease-associated leptin variants.

Authors:  Ellinor Haglund; Lannie Nguyen; Nicholas Peter Schafer; Heiko Lammert; Patricia Ann Jennings; José Nelson Onuchic
Journal:  J Biol Chem       Date:  2018-06-27       Impact factor: 5.157

2.  Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target.

Authors:  Marco Tutone; Licia Pantano; Antonino Lauria; Anna Maria Almerico
Journal:  J Mol Model       Date:  2014-05-06       Impact factor: 1.810

3.  In silico analyses of leptin and leptin receptor of spotted snakehead Channa punctata.

Authors:  Amrita Bakshi; Umesh Rai
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

Review 4.  Comparative endocrinology of leptin: assessing function in a phylogenetic context.

Authors:  Richard L Londraville; Yazmin Macotela; Robert J Duff; Marietta R Easterling; Qin Liu; Erica J Crespi
Journal:  Gen Comp Endocrinol       Date:  2014-02-11       Impact factor: 2.822

5.  Ligand-induced architecture of the leptin receptor signaling complex.

Authors:  Liliya V Mancour; Hikmat N Daghestani; Somnath Dutta; Gerwin H Westfield; Justin Schilling; Austin N Oleskie; Jeffrey F Herbstman; Steven Z Chou; Georgios Skiniotis
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

Review 6.  Leptin-cytokine crosstalk in breast cancer.

Authors:  Gale Newman; Ruben Rene Gonzalez-Perez
Journal:  Mol Cell Endocrinol       Date:  2013-04-04       Impact factor: 4.102

7.  A Miniature Protein Stabilized by a Cation-π Interaction Network.

Authors:  Timothy W Craven; Min-Kyu Cho; Nathaniel J Traaseth; Richard Bonneau; Kent Kirshenbaum
Journal:  J Am Chem Soc       Date:  2016-01-26       Impact factor: 15.419

8.  Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.

Authors:  Xiang Yi; Dongfen Yuan; Susan A Farr; William A Banks; Chi-Duen Poon; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-02       Impact factor: 9.776

9.  Leptin and leptin receptor: analysis of a structure to function relationship in interaction and evolution from humans to fish.

Authors:  J W Prokop; R J Duff; H C Ball; D L Copeland; R L Londraville
Journal:  Peptides       Date:  2012-10-17       Impact factor: 3.750

10.  The unique cysteine knot regulates the pleotropic hormone leptin.

Authors:  Ellinor Haglund; Joanna I Sułkowska; Zhao He; Gen-Sheng Feng; Patricia A Jennings; José N Onuchic
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.